Acute schistosomiasis (Katayama fever): clinical deterioration after chemotherapy

Methodology and scope of peer-reviewed evaluations of TB programmes in high-incidence settings: a scoping review.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2026

Early interventions reduce multimorbidity and TB disability in Kenya, Uganda, Zambia, and Zimbabwe.

IJTLD open·2026

Operational research to End TB: 2nd edition of the Union's Guide to operational research.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2025

Kartagener Syndrome: A First Report of Two Cases from Benin, West Africa.

West African journal of medicine·2025

Evaluating disability, comorbidities and risk factors after TB treatment: an 18-24 month follow-up.

IJTLD open·2025

TB disability and multimorbidity at the onset of treatment in Kenya, Uganda, Zambia and Zimbabwe.

IJTLD open·2025

Epidemiological trends, health inequality, and forecasting of Brucellosis in Mainland China, 2004-2030.

The Journal of infection·2026

Epidemiology and outcomes of Group A streptococcal and non-Group A streptococcal septic arthritis in French children between 2010 and 2023, a national cohort analysis, and case-control study.

The Journal of infection·2026

Dual-species interactions with intestinal bacteria drive multi-drug resistance in Campylobacter.

The Journal of infection·2026

Risk Stratification for Tuberculosis Reactivation in Patients Receiving Biological and Non-biological Immunomodulators: A Review of Current Literature.

The Journal of infection·2026

Protective immunity to clinical malaria is modified by the genetic diversity of P. falciparum antigens.

The Journal of infection·2026

Long-term mortality and late sequelae after bacterial meningitis: A matched cohort study with six decades of follow-up.

The Journal of infection·2026

Related Experiment Videos

Acute schistosomiasis (Katayama fever): clinical deterioration after chemotherapy

Related Concept Videos

Methodology and scope of peer-reviewed evaluations of TB programmes in high-incidence settings: a scoping review.

Early interventions reduce multimorbidity and TB disability in Kenya, Uganda, Zambia, and Zimbabwe.

Operational research to End TB: 2nd edition of the Union's Guide to operational research.

Kartagener Syndrome: A First Report of Two Cases from Benin, West Africa.

Evaluating disability, comorbidities and risk factors after TB treatment: an 18-24 month follow-up.

TB disability and multimorbidity at the onset of treatment in Kenya, Uganda, Zambia and Zimbabwe.

Epidemiological trends, health inequality, and forecasting of Brucellosis in Mainland China, 2004-2030.

Epidemiology and outcomes of Group A streptococcal and non-Group A streptococcal septic arthritis in French children between 2010 and 2023, a national cohort analysis, and case-control study.

Dual-species interactions with intestinal bacteria drive multi-drug resistance in Campylobacter.

Risk Stratification for Tuberculosis Reactivation in Patients Receiving Biological and Non-biological Immunomodulators: A Review of Current Literature.

Protective immunity to clinical malaria is modified by the genetic diversity of P. falciparum antigens.

Long-term mortality and late sequelae after bacterial meningitis: A matched cohort study with six decades of follow-up.

Related Experiment Videos

Acute schistosomiasis (Katayama fever): clinical deterioration after chemotherapy

Related Concept Videos

Related Articles